August 3, 2014

Reducing Seizures in Angelman Syndrome

Dietary Treatment Proven Successful in Reducing Seizures in Angelman Syndrome by up to 90 Percent The Angelman Syndrome Foundation (ASF) is very excited to announce today that clinical research published in Epilepsia on July 10 has found that a low glycemic index […]

Read more
August 28, 2013

Research on Topoisomerase Inhibitors

University of North Carolina-Chapel Hill Research Overview and Frequently Asked Questions The Angelman Syndrome Foundation previously supported breakthrough research showing that topoisomerase inhibitors—specifically, topotecan, an FDA-approved drug used in cancer treatments—activates the paternal allele of Ube3a, identifying a possible treatment […]

Read more
June 18, 2013

ASF Invests $1.25 Million in Research

Angelman Syndrome Foundation Invests $1.25 Million in Research The Angelman Syndrome Foundation (ASF) announced today that because of the generosity of its supporters the organization has awarded $1.25 million to six research grants focused on finding treatments and defining the […]

Read more
May 21, 2012

Possible Cause of Seizures in Angelman Syndrome

Research Reveals Possible Root Cause of Seizures in Autism-related Angelman Syndrome Research published on June 6th in the scientific peer-reviewed journal Neuron has discovered the possible underlying cause of seizures in individuals with Angelman syndrome, a neuro-genetic disorder similar to autism that […]

Read more
March 21, 2012

Possible Treatment for Angelman Syndrome

Research Reveals Possible Treatment for Autism-related Angelman Syndrome Research published today in the scientific peer-reviewed journal Nature has discovered a potential treatment for Angelman syndrome, a neuro-genetic disorder similar to autism that occurs in one in 15,000 live births. By creating the […]

Read more